Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Cord Blood Bank is one of the seven licensed cord blood banking facilities in the People's Republic of China, providing specialized services for the collection, processing, and long-term cryopreservation of umbilical cord blood. The bank operates both a public repository for altruistic donations and a private repository for family-funded storage, focusing on the preservation of hematopoietic stem cells. These cells are used in life-saving transplants for patients suffering from various hematological malignancies, genetic blood disorders, and immune system failures. Managed by Guangzhou Municipality Tianhe Nuoya Bio-engineering, it serves as a critical infrastructure component for regenerative medicine and stem cell research in the Guangdong province. The company maintains stringent quality standards to ensure the viability of stored units for clinical use in hospitals across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Cord Blood Bank.